Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14665160 | 0.75 | TDP1 (0.38) | TDP1 | |
| SCHEMBL8380538 | 0.75 | TDP1 (0.38) | TDP1 | |
| SCHEMBL8974850 | 0.74 | TDP1 (0.33) | TDP1 | |
| SCHEMBL77854 | 0.73 | CES2 (0.35) | — | |
| SCHEMBL12505309 | 0.72 | TDP1 (0.40) | TDP1 | |
| SCHEMBL8380273 | 0.72 | TDP1 (0.40) | TDP1 | |
| SCHEMBL9006867 | 0.68 | TDP1 (0.36) | TDP1 | |
| SCHEMBL12723028 | 0.67 | — | — | |
| SCHEMBL16245491 | 0.67 | — | — | |
| SCHEMBL8974861 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2831226-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-2831252-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-2831251-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-2831250-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| EP-2831253-B1 | ENZYMES USEFUL FOR PERACID PRODUCTION | DUPONT US HOLDING LLC (US) | 2021-11-24 | — | — | EP | disclosed |
| CN-104988187-B | Production of peracids using enzymes having perhydrolytic activity | 纳幕尔杜邦公司 | 2021-02-05 | — | — | CN | disclosed |
| CN-104350154-B | Enzymes useful for peracid production | 纳幕尔杜邦公司 | 2020-12-29 | — | — | CN | disclosed |
| EP-2654695-B1 | ENZYMATIC PERACID GENERATION FOR USE IN ORAL CARE PRODUCTS | DU PONT (US) | 2020-01-22 | — | — | EP | disclosed |
| EP-2342326-B1 | STABILIZATION OF PERHYDROLASES WITH EXCIPIENTS | DU PONT (US) | 2019-05-01 | — | — | EP | disclosed |
| EP-2342349-B1 | STABILIZATION OF PERHYDROLASES IN A FORMULATION WITH A CARBOXYLIC ACID ESTER | DU PONT (US) | 2017-04-05 | — | — | EP | disclosed |
| US-20090312420-A1 | Production Of Peracids Using An Enzyme Having Perhydrolysis Activity | DUPONT US HOLDING, LLC | 2009-12-17 | — | — | US | disclosed |
| US-20090311763-A1 | Production Of Peracids Using An Enzyme Having Perhydrolysis Activity | DUPONT US HOLDING, LLC | 2009-12-17 | — | — | US | disclosed |
| US-20090305366-A1 | Reacting a glyceride, an acetylated saccharide or other ester such a mono- or diester of a glycol with a source of peroxygen in the presence of an enzyme of the CE-7 family of carbohydrate esterases, including cephalosporin acetyl hydrolases and acetyl xylan esterases | DUPONT US HOLDING, LLC | 2009-12-10 | — | — | US | disclosed |
| US-7563758-B2 | Enzymatic production of peracids using Lactobacilli having perhydrolysis activity | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-07-21 | — | — | US | disclosed |
| EP-1941048-B1 | ENZYMATIC PRODUCTION OF PERACIDS USING LACTOBACILLI HAVING PERHYDROLYSIS ACTIVITY | DU PONT (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20090005590-A1 | Production Of Peracids Using An Enzyme Having Perhydrolysis Activity | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-01-01 | — | — | US | disclosed |
| US-20080176783-A1 | Production of Peracids Using An Enzyme Having Perhydrolysis Activity | DUPONT US HOLDING, LLC | 2008-07-24 | — | — | US | disclosed |
| US-20080176299-A1 | PRODUCTION OF PERACIDS USING AN ENZYME HAVING PERHYDROLYSIS ACTIVITY | DUPONT US HOLDING, LLC | 2008-07-24 | — | — | US | disclosed |
| US-20070184999-A1 | Enzymatic production of peracids using lactobacilli having perhydrolysis activity | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-08-09 | — | — | US | disclosed |
| US-20070082832-A1 | Enzymatic production of peracids from carboxylic acid ester substrates using non-heme haloperoxidases | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005590-A1 | Production Of Peracids Using An Enzyme Having Perhydrolysis Activity | CES2, CA7, HAO2 | TDP1 1860/4885 |
| US-20090312420-A1 | Production Of Peracids Using An Enzyme Having Perhydrolysis Activity | CES2, CA7, HAO2 | TDP1 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.